IRF8 defines the epigenetic landscape in postnatal microglia, thereby directing their transcriptome programs

Keita Saeki1, Richard Pan2,3, Eunju Lee2

  • 1Division of Developmental Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. saekik2@nih.gov.

Nature Immunology
|September 23, 2024
PubMed

Insights

Interferon regulatory factor 8 (IRF8) is crucial for microglia development and identity. Deleting IRF8 causes loss of microglia traits and exacerbates Alzheimer's disease pathology in mice.

Area of Science:

  • Neuroscience
  • Immunology
  • Epigenetics

Background:

  • Microglia are the brain's innate immune cells.
  • Transcription factor IRF8 is highly expressed in microglia, but its role in postnatal development is unclear.

Purpose of the Study:

  • To investigate the role of IRF8 in postnatal microglia development and function.
  • To understand how IRF8 influences the epigenetic landscape and gene expression in microglia.

Main Methods:

  • Chromatin immunoprecipitation sequencing (ChIP-seq) to identify IRF8 binding sites.
  • Single-cell RNA sequencing (scRNA-seq) and single-cell ATAC-seq (scATAC-seq) for multi-omic analysis.
  • Genetic deletion of IRF8 in mouse models, including the 5xFAD Alzheimer's disease model.

Main Results:

  • IRF8 binds to enhancers in developing microglia, correlating with increased chromatin accessibility and microglia-specific gene expression.
  • Loss of IRF8 leads to a loss of microglial identity and a gain of disease-associated microglia (DAM) signatures.
  • IRF8 is essential for establishing microglia-specific DNA methylation patterns.
  • IRF8 deletion in 5xFAD mice reduces amyloid-beta plaque interaction, plaque size, and neuronal loss.

Conclusions:

  • IRF8 plays a critical role in establishing the epigenetic landscape necessary for postnatal microglia gene expression and identity.
  • IRF8 is a key regulator of microglial maturation and function, impacting neuroinflammation and neuroprotection in Alzheimer's disease models.